Tadalafil

他达拉非

Report date: 2026/03/27 20:01:50
NME

Base Information

Drug NameTadalafil
Drug Alias NameTadalafilumTadalafiloAdcirca西力士Cialis +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsIschemic StrokeSexual Dysfunctions, PsychologicalDepressive Disorder, Major +[36] 
Global Approved IndicationsErectile DysfunctionProstatic Hyperplasia
Approved Indications in ChinaErectile DysfunctionProstatic Hyperplasia
Original Approved Country/TerritoryEU
Original Approved Date2002/11/12
Country/TerritoryBelgiumCanadaUnited States +[32] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CopenhagenWashington University School Of MedicineMenarini Group +[21] 
Inactive CompaniesUtah State UniversityCarelon ResearchIcos Corporation +[21] 
Active IndicationsIschemic StrokeLower Urinary Tract SymptomsObesity +[18] 
Inactive IndicationsSexual Dysfunctions, PsychologicalDepressive Disorder, MajorUlcer +[18] 

Other Information

ATC CodeG04BE08
Related LinksWikipediaDrugBankKEGG